Tevogen Bio Holdings (TVGN) | Stock Overview & Key Data

Tevogen Bio Holdings Inc. | Healthcare

$1.41

8.46%

| Tevogen Bio Holdings Stock Comparison:

Tevogen Bio Holdings vs Vertex Tevogen Bio Holdings vs Regeneron Tevogen Bio Holdings vs Monte Rosa Tevogen Bio Holdings vs Astria Therapeutics Tevogen Bio Holdings vs Ocugen Tevogen Bio Holdings vs S&P 500 | Market

Chart Range Statistics Financials Returns Ownership Calculator FAQ

Tevogen Bio Holdings Performance Comparison

Loading chart data...

Tevogen Bio Holdings

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: $1.27 High: $1.42

on June 5, 2025

52 Week Range

Low: $0.26 High: $3.09

on October 9, 2024

on October 25, 2024

All-Time High: $21.09 on February 12, 2024

Key Statistics

Market Cap i $246.4M

EPS i -0.22

P/E Ratio (TTM) i 2.86

Forward P/E i N/A

P/B Ratio i -26.97

PEG Ratio i 0.00

Div. Yield i 0.00%

ROE i 205.68%

Beta i -0.795

Debt to Equity i -0.62

Financial Highlights

Profitability

Gross Margin i N/A

Operating Margin i 0.00%

Profit Margin i 0.00%

Returns and Earnings

Return on Assets (TTM) i -578.29%

Return on Equity (TTM) i 205.68%

EBITDA i $-34.2M

Net Income (TTM) i $-31.3M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i N/A

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Tevogen Bio Holdings TVGN	246.42M Micro-cap	5.22%	33.02%	18.49%	34.29%	33.02%	71.08%	-69.46%	-69.46%
Vertex VRTX	114.81B Large-cap	-0.73%	-11.27%	-9.73%	-3.50%	9.38%	-8.12%	74.12%	65.25%
Regeneron REGN	65.36B Large-cap	-20.21%	-19.97%	-29.70%	-37.09%	-32.46%	-51.86%	-15.56%	-17.94%
Monte Rosa GLUE	281.10M Small-cap	9.22%	-0.22%	-23.76%	-47.68%	-35.02%	16.08%	-37.14%	-75.50%
Astria Therapeutics ATXS	284.71M Small-cap	5.45%	2.15%	-16.21%	-46.46%	-41.81%	-41.13%	85.41%	-86.74%
Ocugen OCGN	243.61M Micro-cap	14.46%	25.00%	66.67%	9.20%	5.56%	-40.63%	-56.22%	251.85%

Ownership & Short Interest

Insider Ownership i 80.65%

Institutional Ownership i 2.18%

Shares Short i 2M

Short Ratio i 1.22

Short % of Shares Outstanding i 3.86%

Average 10-Day Volume i 497K

Average 90-Day Volume i 1M

Tevogen Bio Holdings Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Tevogen Bio Holdings would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is TVGN's 52-week high and low?

In the last 52 weeks, Tevogen Bio Holdings reached a high of $3.09 (on October 25, 2024) and a low of $0.26 (on October 9, 2024).

What is the market cap and P/E ratio for TVGN?

Curious about Tevogen Bio Holdings's size and valuation? Its market capitalization stands at 246.42M. When it comes to valuation, the P/E ratio (trailing twelve months) is 2.86, and the forward P/E (looking ahead) is N/A.

Does TVGN pay dividends? If so, what's the yield?

As for dividends, Tevogen Bio Holdings isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Tevogen Bio Holdings's main competitors or similar companies to consider before investing?

When looking at Tevogen Bio Holdings, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Vertex VRTX	114.81B	Healthcare	Biotechnology	-8.12%	74.12%
Regeneron REGN	65.36B	Healthcare	Biotechnology	-51.86%	-15.56%
Monte Rosa GLUE	281.10M	Healthcare	Biotechnology	16.08%	-37.14%
Astria Therapeutics ATXS	284.71M	Healthcare	Biotechnology	-41.13%	85.41%
Ocugen OCGN	243.61M	Healthcare	Biotechnology	-40.63%	-56.22%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Tevogen Bio Holdings Inc.? (e.g., ROE, Debt/Equity)

To get a sense of Tevogen Bio Holdings's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 205.68%, the Debt to Equity ratio from the most recent quarter is -0.62, and its Gross Profit Margin stands at N/A.

What is the recent revenue and earnings growth for TVGN?

Looking at Tevogen Bio Holdings's growth, its revenue over the trailing twelve months (TTM) was $0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.

How much of TVGN stock is held by insiders and institutions?

Wondering who owns Tevogen Bio Holdings stock? Company insiders (like executives and directors) hold about 80.65% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 2.18%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.